Filing Details

Accession Number:
0001179110-18-010698
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-20 13:46:15
Reporting Period:
2018-08-16
Accepted Time:
2018-08-20 13:46:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1298819 A Robert Sinnott 3838 West Parkway Blvd
Salt Lake City UT 84120
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-16 7,211 $65.48 7,211 No 4 M Direct
Common Stock Disposition 2018-08-16 7,211 $129.39 0 No 4 S Direct
Common Stock Acquisiton 2018-08-17 7,530 $65.48 7,530 No 4 M Direct
Common Stock Disposition 2018-08-17 7,530 $128.73 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock-Settles Stock appreciation Right Disposition 2018-08-16 14,645 $0.00 14,645 $65.48
Common Stock Stock-Settles Stock appreciation Right Disposition 2018-08-17 15,355 $0.00 15,355 $65.48
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
105,355 2017-08-16 2022-03-16 No 4 M Direct
90,000 2017-08-16 2022-03-16 No 4 M Direct
Footnotes
  1. The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II
  2. Weighted average price. Price range in multiple transactions was $129.00 to $129.90, inclusive.
  3. Weighted average price. Price range in multiple transactions was $128.50 to $129.45, inclusive.